在严重抑郁症中使用Esketamine鼻喷雾:对随机对照试验的元分析
Zhibin Wang1, Lili Jiang2, Wenzhuang Ma3
1Department of Pain Management, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Clinical pharmacology and therapeutics
|January 10, 2025
概括
当与抗抑郁药物一起使用时,Esketamine鼻喷剂有效治疗主要抑郁症和耐治疗抑郁症,减少短期和长期症状. 支持其有效性和安全性的证据具有中等到高的确定性.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 重度抑郁症 (MDD) 和耐治疗性抑郁症 (TRD) 构成了全球重大健康挑战.
- 尽管有监管部门的批准,但埃斯基坦胺鼻喷剂作为MDD的辅助治疗的有效性仍然是持续辩论的主题.
- 现有的研究需要对不同患者群体中埃斯基他明的性能进行全面评估.
研究的目的:
- 系统地评估esketamine鼻雾剂作为MDD和TRD的附加治疗方法的疗效和安全性.
- 评估在接受ESKETAMINE鼻喷雾的患者中短期症状减缓和长期复发率.
- 根据严格的元分析,确定证据证据的确定性,以埃斯凯他明的治疗效果为基础.
主要方法:
- 在Embase,Pubmed和Web of Science数据库中进行了全面的文献搜索.
- 在MDD/TRD患者中,随机对照试验 (RCT) 确定了比较esketamine鼻喷雾剂与安慰剂或活性对照剂的随机对照试验.
- 主要结局包括蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 的变化和复发率;证据确定性是使用Cochrane指南进行评估的.
主要成果:
- 在没有自杀念头的患者28日 (SMD: -0.24) 和自杀念头的患者2日 (SMD: -0.30) 中,Esketamine鼻喷剂在降低MADRS评分方面明显优于安慰剂.
- 与安慰剂/quetiapine (RR:0.60) 相比,在乙胺组中,长期复发率明显较低.
- 两组之间没有观察到自杀念头率的显著差异;证据确定性被评为中等至高.
结论:
- 作为辅助疗法,Esketamine鼻喷剂有效地管理MDD和TRD的短期和长期抑郁症状.
- 这些发现支持埃斯基他鼻喷雾剂的良好疗效和安全性,具有可管理的风险/益处平衡.
- 证据的中等到高确定性强调了这些发现对临床决策的可靠性.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
335
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
335
01:27Depressive Disorders: MDD and Dysthymia
70
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
70
01:30Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
159
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
159
01:25Antidepressant Drugs: Overview
389
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
389